The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird's eye view of the Biotechnology industry. Annotated with 26 fact, and data rich tables presenting analytical segmentation by product application, the report provides global revenues, and expenditure on R&D of/by biotechnology companies, sales of enabling technologies, biologic drug sales by product and global biotech/pharmacogenomics/bioinformatics product/technology sales, among others. The report offers a sneak peek into major end-use industries, taking note of select trends in Genomics, Biochips, Biologics and Biopharmaceutical Intermediates, Biogenerics, Biotechnology Instruments, and Biotechnology Reagents, among others. Also included is a compilation of all recent mergers, acquisitions, and strategic corporate developments. A regional-level of discussion mirrors the prevalent scenario in key regional markets such as the US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland, New Zealand, India, Malaysia, and Brazil, among few others. The report also includes an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 2,220 companies worldwide.

1.Biotechnology
- Global Market Overview
- Major companies
- Market for "Follow-On" Biologics
- Market for Marine Biotechnology
- Major Trends
- Business Deals Involving Collaborations, Acquisition and Joint Ventures to Drive Up Biotech Sales
- Biotech Acquisitions Getting More Focused
- Contract Manufacturing - A New Business Motto for Biotechnology Companies
- Oncology Dominates Biotech Drugs Sale
- Investment on Research: Vital for the Survival of Biotech Companies
- Asia-Pacific: A Promising Market for Biopharmaceutical Companies
- Biotech Regenerative Medicine Catching On
- Reverse Merger Transactions Characterizes the Asian Biotech Sector
- Biotech Instrumentation to Speed Up Biotech Research Process
- Growth of Bioventure Startups in Japan
- Advent of "Mid-Tier" Companies in the Biotech Market
- Biogenerics Poised for a Big Entry
- Development of DNA Vaccines
- The Development of Nano-Sized Delivery Systems Poses Problem in the Biotech Sector
- Issues Related to Pricing and Reimbursement of Biotech Drugs
- End-Use Industries
- Overview of Agricultural and Food Biotechnology
- Plants Based Drugs - Innovative Agri Biotech Products
- Consolidated Trends
- Outlook of Health and Medical Biotechnology
- Biotech Technologies/Fields of Medical & Health Sector
- Bioinformatics
- Market Players
- Genomics
- Market Trends
- Influencing Factors
- Growth Driving Factors
- Novel Business Area
- Market Players
- Pharmacogenomics
- Overview
- Biochips
- Overview of the Biochip Industry
- Biochip Technology
- Building Bio Chips
- Inexpensive Testing
- Motorola, First Biochip Manufacturer
- Tech Giants Join the Biochip Fray
- Biologic Drugs
- Market Overview
- Major Drugs
- Biopharmaceutical and Small Drug Discovery
- Market Overview
- Role of Key Players
- Market Players
- Biologics and Biopharmaceutical Intermediates
- Market Trends
- Driving Factors
- Biological Technologies and Services (A Historic Review)
- Research and Development Expenditure
- Biopharmaceutical Companies
- Cell and Tissue Culture
- Market Overview
- Market Trends
- Surging Demand for Cell Culture Products
- Proteomics and Pharmacokinetics Drive Market Growth
- Regulations Prompt Change in Trends
- Biotechnology Instruments
- Market Overview
- Growth Trends
- Biotechnology - Major Impact on Analytical Instruments Market
- Innovations and Discoveries - Fuel Demand for Biotech Instrumentation
- Technological Developments Influence Market Growth
- Market Players
- Biotechnology Reagents
- Market Overview
- Market Trends
- Highly Automated Instrumentation Restricts Use of Reagents
- Molecular Biology and Protein Synthesis Reagents are Growing Rapidly
- Environmental and Industrial Biotechnology
- Nanophase Technologies Corp., (NTC) in BioTechnology
2.Mergers and Acquisitions
3.Strategic Corporate Developments
4.Product Launches & Developments
$1 MARKET PERSPECTIVE
1.North America
- 1a.The United States
  - Overview
  - Agricultural Biotechnology
  - Market Overview
  - Market Trends
  - Success Stories and Demand
  - Market Players
  - Medical Biotechnology - Market Overview
  - Eye on different fields of Medical Biotech
  - Bioinformatics
  - Regulatory Environment
  - Proteomics
  - Biochips
  - Patient Applications
- 1b.Canada
  - Market Overview
  - Facts of Canadian Biotechnology Industry
- 1c.Mexico
  - Biotechnology - Market Overview
  - End-Use Industries
  - Bio-Pharmaceuticals
  - Food Biotechnology
  - Environmental Biotechnology
2.Japan
- Biotechnology Market Overview
- End-Use Industries
- Medical Biotechnology and Healthcare
- Bioinformatics
- Food Biotechnology Industry
- Environmental Biotechnology
- Bioremediation
- Biodegradable Plastics
3.A European Market Perspective
- Industry Overview
- 3a.Denmark
- 3b.France
  - Overview
- 3c.Germany
  - Overview
- 3d.Italy
  - Overview
- 3e.Poland
  - Overview
  - Market Access Regulations
- 3f.United Kingdom
  - Medical Biotechnology and Healthcare Sector
  - Agricultural Biotechnology
- 3g.Sweden
  - Overview
- 3h.Switzerland
  - Overview
4.Asia-Pacific
- Overview
- 4a.Australia
  - Overview
- 4b.New Zealand
  - Overview
- 4c.China
- 4d.India
  - Market Overview
  - Booming Biotechnology Industry
  - Bio-pharma Drives Growth in Biotech Industry
  - Growth in Industry Sparks Investments
  - Transformation - Creating a Platform for Future Growth in Biotech Industry
- 4e.Malaysia
  - Overview of Malaysian Biotechnology Industry
  - Role of National Biotechnology Directorate (Biotek)
  - Market Trends
- 4f.South Korea
  - Biotechnology Industry Overview
- 4g.Taiwan
5.Other Markets
- 5a.Argentina
- 5b.Brazil
  - Industry Outlook
  - End-Use Industries
  - Diagnostics
  - Biotechnology and Animal Health
  - Agricultural Biotechnology
  - Environmental Biotechnology
  - Biotechnology in Food Processing
- 5c.Israel
Global Directory
List of Tables
- Table 1: Global Biotechnology Market by Product Application - Antibiotics, Intermediates/ Biopharmaceuticals, Food/Feed, Industrial Enzymes, Environmental Applications, Biodegradable Polymers, and Agrochemical Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2003 through 2008
- Table 2: Global Biotechnology Market (2004 & 2008): Percentage Breakdown of Value Sales by Product Application - Antibiotics, Intermediates/ Biopharmaceuticals, Food/Feed, Industrial Enzymes, Environmental Applications, Biodegradable Polymers, and Agrochemical
- Table 3: Leading Players in the Global Biotechnology Market (2005 & 2006): Revenues in US$ Million for Amgen, Genentech, Genzyme, UCB SA, Gilead Sciences, Serono, Biogen Idec, CSL, Cephalon, MedImmune, Celgene, Abraxis BioScience, Actelion, ImClone Systems, Elan, Amylin Pharmaceuticals, Millennium Pharmaceuticals, PDL BioPharma, OSI Pharmaceuticals, and MGI Pharma
- Table 4: Leading Players in the Global Biotechnology Market (2003): Expenditure on Research and Development in US$ Million for Amgen, Genentech, Biogen Idec, Serono, Genzyme, Chiron, MedImmune, Cephalon, Millennium Pharmaceuticals, Gilead Sciences, and Others
- Table 5: Global Biotechnology Market by Category: Enabling Technologies and Star Products Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2003 through 2008
- Table 6: Global Biotechnology Market: Revenues in US$ Billion for Years 2003 through 2008
- Table 7: Leading Products in the Global Biotechnology Market (2007): Sales in US$ Million for Aranesp, Enbrel, Remicade, Erypo/Procrit, Neulasta, MabThera/Rituxan, Epogen, Herceptin, Avastin, and Humira
- Table 8: Global Bioinformatics Technology Market: Revenues in US$ Million for Years 2003 through 2008
- Table 9: Leading Players in the Global Genomics Market (2005): Revenues in US$ Million for Millennium Pharmaceuticals, Myriad Genetics, Lexicon Genetics, Celera Genomics, CuraGen, Human Genome Sciences, Maxygen, and Incyte
- Table 10: Global Pharmacogenomics' Market by Type: Cardiovascular Disease, Infectious Disease, Central Nervous System, Cancer, and Others Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008
- Table 11: Global Pharmacogenomics' Market (2004): Percentage Breakdown of Value Sales for Cardiovascular Disease, Infectious Disease, Central Nervous System, Cancer, and Others
- Table 12: Global Biochip Market by Chip Type: DNA Chips and Protein Chips Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008
- Table 13: Leading Categories in the Global Biologic Drug Market (2005): Sales in US$ Billion for Erythropoietins (Aranesp, Procrit, Eprex, Epogen, Neo-Recormon), TNF (Enbrel, Remicade, Humira), Major Cancer Antibodies (Rituxan/MabThera, Herceptin, Avastin, Erbitux), Interferon Beta (Avonex, Rebif, Betaferon/Betaseron), G-CSF (Neulasta, Neupogen, Neutrogin), Rec. Coagulation Factors (Novoseven, Kogenate, Refacto, Benefix), Interferon Alpha (Pegasys, Pegintron, Intron A), Enzyme Replacement (Cerezyme, Fabrazyme, Aldurazyme), Antiviral Antibody (Synagis) and Follicle Stimulating Hormones (Gonal-F, Puregon)
- Table 14: Global Biologics or Biopharmaceutical Intermediates Market by Leading Technologies and Services - Microbial Fermentation, Mammalian Cell Culture, Biopharmaceutical Fill and Finish, Transgenics, and Other Manufacturing Services Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008
- Table 15: Global Biologics or Biopharmaceutical Intermediates Market (2004 & 2008): Percentage Breakdown of Value Sales for Microbial Fermentation, Mammalian Cell Culture, Biopharmaceutical Fill and Finish, Transgenics, and Other Manufacturing Services
- Table 16: Global Biopharmaceutical Market (2003): Research and Development Expenditures in US$ Million for Pfizer, Johnson & Johnson, GlaxoSmithKline, Sanofi-Aventis Group, Novartis, Roche, Merck, AstraZeneca, Eli Lilly, Wyeth, and Others
- Table 17: Leading Players in the US Biotechnology Market (2006): Sales in US$ Million for Amgen, Roche (Genentech), Johnson & Johnson, Lilly, Novo Nordisk, Sanofi-Aventis, Abbott, Biogen Idec, Serono, and Medimmune
- Table 18: Leading Products in the US Biotechnology Market (2006): Sales in US$ Million for Aranesp, Epogen, Enbrei, Neulast, Procrit, Remicade, Rituxan, Avastin, Lantus, and Herceptin
- Table 19: Biotechnology Market in the US: Percentage Breakdown of Value Product Sales by Sector - Therapeutics, Diagnostics, Agriculture, Chemicals and Others
- Table 20: Agricultural Biotech Market in the US by Product Segment - Transgenic Seeds/Crops (Soybean, Corn, Cotton, Others), and Biopesticides Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008
- Table 21: Agricultural Biotech Market in the US (2004 & 2008): Percentage Breakdown of Value Sales for Transgenic Seeds/Crops (Soybean, Corn, Cotton and Others), and Biopesticides
- Table 22: Biotechnology Market in Canada: Revenues in US$ Billion for Years 2004 through 2010
- Table 23: Biotechnology Market in Switzerland (2005): Percentage Breakdown of Value Sales by Sector - Engineering, Therapeutics & Diagnostics, Technologies, Contract Research & Manufacturing, Bioelectronics & Bioinformatics, Bio and Specialty Chemicals, Environmental Technologies, Agricultural and Food Processing Service Providers & Supporters
- Table 24: Biotechnology Market in New Zealand (2005): Percentage Breakdown of Value Sales by Sector - Biotech Suppliers & Service Providers, Human Therapeutics, Agricultural Biotechnology, Chemical & Environmental Biotech, Food & Beverages, Bioinformatics, Diagnostics, and Others
- Table 25: Biotechnology Market in Korea (2004 & 2005): Production in US$ Billion
- Table 26: Biotechnology Market in Brazil (2005): Percentage Breakdown of Value Sales by Sector - Human Health, Biotechnology Companies, Consumables Suppliers, Equipment, Agribusiness, Animal Health, and Environment

Pharmaceutical Market Research

Biotechnology

Biotechnology

Contents

Related products